Clinical Trials
COVALENT-111
A phase 1/2 clinical trial in healthy adults and adults with Type 2 diabetes.
–
COVALENT-112
A Phase 2 clinical trial for adults with stage 3 Type 1 Diabetes
COVALENT-101
A phase 1 clinical trial for patients with relapsed or refractory AML, ALL, DLBCL, MM or CLL/SLL.
–
–
COVALENT-102
A phase 1/1b clinical trial for patients with KRAS mutant, unresectable, locally advanced/metastatic NSCLC, PDAC, and CRC.
–
COVALENT-103
A Phase 1 clinical trial for adults with FLT3 mutant Acute Leukemia.